World Child Cancer USA shared a post on LinkedIn:
“Earlier this year, we proudly joined Access Cancer Treatment (ACT) for Children-a collaborative initiative aligned with the WHO CureAll framework to address inequities in pediatric cancer care across LMICs.
Last week, we came together for the first partners’ meeting to reflect on our shared journey and shape the road ahead. What stood out was the unwavering commitment, deep collaboration, and compassion each partner brings to this mission.
In just 3 months, this powerful collaboration has delivered $2.3 million worth of quality-assured essential medicines—at no cost—to four childhood cancer centers across Asia and Central America…and we’re just getting started.”
More posts featuring World Child Cancer USA on OncoDaily.
